Regulation & law · 18/09/2006

Nasdaq Approves Rule Change to Shorten Cure Period for Companies Losing Independent Directors or Audit Committee Members

The Nasdaq Stock Market LLC has granted approval to a proposed rule change that reduces the cure period for companies that lose independent directors or audit committee members, allowing for faster recovery and compliance